Article Details
Retrieved on: 2025-01-22 17:59:04
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Buoyed by cardiovascular acquisitions, J&J still reported strong 2024 results for its medtech business.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here